Skip to content

Efficacy of postbiotics in acute enteritis

Efficacy of postbiotics for symptom control and prevention of post-infectious irritable bowel syndrome (PI-IBS) in patients with acute infectious diarrhea

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0007914
Enrollment
80
Registered
2022-11-18
Start date
2022-12-01
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : ? Patients with acute enteritis are enrolled with written consent (Day 1). ? Eligible patients were evaluated using questionnaires about gastrointestinal symptom, and acute enteri

Sponsors

Korea University Ansan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adults aged 19-75 who presented with acute diarrhea without bloody stool within 48 hours - Acute diarrhea is defined as having three or more shapeless stools in the past 24 hours and one or more of the following symptoms. - Abdominal pain, excessive flatulence, nausea, vomiting, rectal urgency, or tenesmus

Exclusion criteria

Exclusion criteria: - pregnant or lactating women - Persons suspected of serious complications due to acute enteritis (renal failure, metabolic acidosis, hypovolemic shock, heart failure…)

Design outcomes

Primary

MeasureTime frame
Proportion of patients with time to last unformed stool (TLUS) within 120 hours (%)

Secondary

MeasureTime frame
Improvement of symptoms of acute enteritis 1) Time to last unformed stool 2) % of patients with TLUS within 48 hours 3) Symptom improvement rate on the 3rd day;Proportion of patients with symptom of irritable bowel syndrome

Countries

Korea, Republic of

Contacts

Public ContactSeung Young Kim

Korea University Ansan Hospital

seung0md@gmail.com+82-31-412-5580

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026